AZD4360
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 02, 2025
Study for AZD4360 in Participants With Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=117 | Recruiting | Sponsor: AstraZeneca | Trial primary completion date: Jul 2027 ➔ Mar 2027
Trial primary completion date • Biliary Cancer • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Oncology • Pancreatic Cancer • Solid Tumor
May 21, 2025
Study for AZD4360 in Participants With Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=117 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting
Enrollment open • Biliary Cancer • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Oncology • Pancreatic Cancer • Solid Tumor
April 11, 2025
Study for AZD4360 in Participants With Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=117 | Not yet recruiting | Sponsor: AstraZeneca
New P1/2 trial • Biliary Cancer • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor
1 to 3
Of
3
Go to page
1